Skip to main content

Development of a Mouse Model for the Study of Human Purine Metabolism

  • Chapter

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 370))

Abstract

Patients with Down syndrome are known to be hyperuricemic and this condition is thought to result from the over-production of purines (Pant et al., 1968). Only one purine metabolism gene is located on human chromosome 21 in the critical region associated with Down syndrome. This gene encodes for the trifunctional protein composed of phosphoribosylglycinamide synthetase (GARS), phosphoribosylglycinamide transformylase (GART) and phosphoribosylaminoimidazole synthetase (AIRS). Increased levels of this protein, known collectively as GART, have also been observed in the cultured fibroblasts of Down Syndrome patients (Scoggin et al., 1980) It is therefore highly likely that the increased levels of purines described in these patients is directly due to their over-expression of the GART trifunctional protein.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Barnes, T. S., Shaw, P. M., Burke, M. D. and Melvin, W. T., 1987, Monoclonal antibodies against human cytochrome P-450 recognizing different pregnenolone16a-carbonitrile-inducible rat cytochromes P-450, Biochem. J. 248:301.

    PubMed  CAS  Google Scholar 

  • Barnes, T. S., Bleskan, J. H., Hart, I. M., Walton, K. A., Barton, J. W. and Patterson, D., 1994, Purification of, generation of monoclonal antibodies to, and mapping of phosphoribosyl N- formylglycinamide amidotransferase, Biochemistry, 33:1850.

    Article  PubMed  CAS  Google Scholar 

  • Pant, S. S., Moser, H. W. and Krane, S. M., 1968, Hyperuricemia in Down’s syndrome, J. Clin. Endocrinol. 28:472.

    Article  CAS  Google Scholar 

  • Scoggin, C. H., Bleskan, J., Davidson, J. N. and Patterson, D., 1980, Gene expression of glycinamide ribonucleotide synthetase in Down syndrome, Clin. Res. 28:31.

    Google Scholar 

  • Wu, X., Wakamiya, M., Vaishnav, S., Geske, R., Montgomery, C., Jr., Jones, P., Bradley, A. and Caskey, C. T., 1994, Hyperuricemia and urate nephropathy in urate oxidase-deficient mice, Proc. Natl. Acad. Sci. USA 91:742.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media New York

About this chapter

Cite this chapter

Barnes, T.S., Brodsky, G.L., Barela, G.J., Bleskan, J.H., Patterson, D. (1995). Development of a Mouse Model for the Study of Human Purine Metabolism. In: Sahota, A., Taylor, M.W. (eds) Purine and Pyrimidine Metabolism in Man VIII. Advances in Experimental Medicine and Biology, vol 370. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2584-4_109

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2584-4_109

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6105-3

  • Online ISBN: 978-1-4615-2584-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics